Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06403761
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-03
Brief Title:
Investigating How CagriSema Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-18
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-03
First Submit QC Date:
May 3 2024
Study First Post Date:
2024-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-23
Last Update Post Date:
2024-05-28
Last Update Post Date Type:
ACTUAL